Abbott Laboratories Current Ratio 2006-2018 | ABT

Current and historical current ratio for Abbott Laboratories (ABT) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Abbott Laboratories current ratio for the three months ending December 31, 2018 was 1.62.
Abbott Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $14.63B $9.01B 1.62
2018-09-30 $18.20B $12.78B 1.42
2018-06-30 $14.12B $8.95B 1.58
2018-03-31 $14.96B $9.01B 1.66
2017-12-31 $20.15B $8.91B 2.26
2017-09-30 $21.38B $7.94B 2.69
2017-06-30 $19.98B $6.80B 2.94
2017-03-31 $19.33B $6.65B 2.91
2016-12-31 $26.78B $6.66B 4.02
2016-09-30 $12.98B $8.32B 1.56
2016-06-30 $12.99B $8.67B 1.50
2016-03-31 $12.41B $8.39B 1.48
2015-12-31 $14.16B $9.19B 1.54
2015-09-30 $15.89B $8.76B 1.82
2015-06-30 $21.13B $9.19B 2.30
2015-03-31 $19.99B $9.21B 2.17
2014-12-31 $13.56B $10.47B 1.30
2014-09-30 $16.46B $10.82B 1.52
2014-06-30 $18.26B $9.85B 1.85
2014-03-31 $17.93B $10.19B 1.76
2013-12-31 $19.25B $9.51B 2.03
2013-09-30 $19.75B $11.33B 1.74
2013-06-30 $19.83B $10.92B 1.82
2013-03-31 $19.10B $10.41B 1.84
2012-12-31 $31.32B $13.28B 2.36
2012-09-30 $27.26B $16.29B 1.67
2012-06-30 $26.26B $17.12B 1.53
2012-03-31 $25.60B $16.79B 1.53
2011-12-31 $23.77B $15.48B 1.54
2011-09-30 $23.09B $15.41B 1.50
2011-06-30 $24.13B $15.84B 1.52
2011-03-31 $23.65B $17.23B 1.37
2010-12-31 $22.32B $17.26B 1.29
2010-09-30 $19.45B $15.58B 1.25
2010-06-30 $19.92B $14.69B 1.36
2010-03-31 $17.69B $15.18B 1.17
2009-12-31 $23.31B $13.05B 1.79
2009-09-30 $21.42B $12.53B 1.71
2009-06-30 $19.63B $12.04B 1.63
2009-03-31 $18.01B $11.77B 1.53
2008-12-31 $17.04B $11.59B 1.47
2008-09-30 $15.23B $9.56B 1.59
2008-06-30 $16.96B $12.02B 1.41
2008-03-31 $15.11B $10.77B 1.40
2007-12-31 $14.04B $9.10B 1.54
2007-09-30 $12.84B $12.28B 1.05
2007-06-30 $12.34B $12.01B 1.03
2007-03-31 $11.50B $12.31B 0.94
2006-12-31 $11.28B $11.95B 0.94
2006-09-30 $10.07B $7.43B 1.36
2006-06-30 $9.90B $7.69B 1.29
2006-03-31 $10.61B $7.16B 1.48
2005-12-31 $11.39B $7.42B 1.54
2005-09-30 $10.99B $8.76B 1.26
2005-06-30 $9.66B $6.08B 1.59
2005-03-31 $10.35B $7.37B 1.41
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $128.012B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $113.636B 16.61
Stryker (SYK) United States $67.248B 24.66
Boston Scientific (BSX) United States $48.542B 23.59
Baxter (BAX) United States $38.022B 24.39
Zimmer Biomet Holdings (ZBH) United States $24.486B 15.67
Smith & Nephew SNATS (SNN) United Kingdom $16.790B 0.00
Canopy Growth (CGC) Canada $14.340B 0.00
ResMed (RMD) United States $13.953B 26.46
Aurora Cannabis (ACB) Canada $9.078B 64.00
Bio-Rad Laboratories (BIO) United States $8.696B 49.88
Perrigo (PRGO) Ireland $6.775B 10.98
Hill-Rom Holdings (HRC) United States $6.356B 19.66
Insulet (PODD) United States $4.935B 1654.40
GW Pharmaceuticals (GWPH) United Kingdom $4.697B 0.00
ICU Medical (ICUI) United States $4.641B 28.74
Haemonetics (HAE) United States $4.169B 36.99
Hutchison China MediTech (HCM) China $4.067B 0.00
Agios Pharmaceuticals (AGIO) United States $3.290B 0.00
Neogen (NEOG) United States $2.877B 46.77
NuVasive (NUVA) United States $2.794B 24.27
Quidel (QDEL) United States $2.380B 21.30
National Vision Holdings (EYE) United States $2.239B 44.05
Aphria (APHA) $1.960B 0.00
HEXO (HEXO) $1.401B 0.00
Phibro Animal Health (PAHC) United States $1.345B 19.33
VAREX IMAGING (VREX) United States $1.192B 23.34
Cardiovascular Systems (CSII) United States $1.182B 848.25
AtriCure (ATRC) United States $1.052B 0.00
Omeros (OMER) United States $0.928B 0.00
Lantheus Holdings (LNTH) United States $0.921B 24.90
PetIQ (PETQ) United States $0.851B 24.36
MacroGenics (MGNX) United States $0.798B 0.00
Cerus (CERS) United States $0.794B 0.00
NanoString Technologies (NSTG) United States $0.741B 0.00
TG Therapeutics (TGTX) United States $0.716B 0.00
Evolus (EOLS) United States $0.659B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.656B 22.33
OraSure Technologies (OSUR) United States $0.593B 25.81
Surmodics (SRDX) United States $0.543B 79.00
LeMaitre Vascular (LMAT) United States $0.532B 25.29
Meridian Bioscience (VIVO) United States $0.531B 15.81
Quanterix (QTRX) United States $0.478B 0.00
Insys Therapeutics (INSY) United States $0.320B 0.00
Utah Medical Products (UTMD) United States $0.316B 20.57
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.309B 0.00
BioLife Solutions (BLFS) United States $0.308B 126.92
Vapotherm (VAPO) United States $0.289B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Owens & Minor (OMI) United States $0.228B 3.12
Cytosorbents (CTSO) United States $0.224B 0.00
Zynex (ZYXI) United States $0.171B 18.28
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.125B 0.00
Chembio Diagnostics (CEMI) United States $0.124B 0.00
Fonar (FONR) United States $0.123B 6.60
Surface Oncology (SURF) United States $0.111B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
United-Guardian (UG) United States $0.086B 19.81
Female Health (VERU) United States $0.081B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Neurotrope (NTRP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 20.34
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.033B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.021B 0.00
Myomo (MYO) United States $0.020B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.03